Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, Georgia 30332-0535, USA.
Biotechnol Bioeng. 2013 Mar;110(3):667-82. doi: 10.1002/bit.24802. Epub 2013 Jan 17.
Cell microencapsulation has been utilized for decades as a means to shield cells from the external environment while simultaneously permitting transport of oxygen, nutrients, and secretory molecules. In designing cell therapies, donor primary cells are often difficult to obtain and expand to appropriate numbers, rendering stem cells an attractive alternative due to their capacities for self-renewal, differentiation, and trophic factor secretion. Microencapsulation of stem cells offers several benefits, namely the creation of a defined microenvironment which can be designed to modulate stem cell phenotype, protection from hydrodynamic forces and prevention of agglomeration during expansion in suspension bioreactors, and a means to transplant cells behind a semi-permeable barrier, allowing for molecular secretion while avoiding immune reaction. This review will provide an overview of relevant microencapsulation processes and characterization in the context of maintaining stem cell potency, directing differentiation, investigating scalable production methods, and transplanting stem cells for clinically relevant disorders.
细胞微囊化技术已经被应用了几十年,它可以保护细胞免受外部环境的影响,同时允许氧气、营养物质和分泌分子的运输。在设计细胞疗法时,供体原代细胞通常难以获得和扩增到适当的数量,因此干细胞由于其自我更新、分化和营养因子分泌的能力成为一种有吸引力的替代方法。干细胞的微囊化提供了几个好处,即创建一个可以设计来调节干细胞表型的定义微环境,保护干细胞免受流体动力的影响,并防止在悬浮生物反应器中扩增时的聚集,以及一种将细胞移植到半透性屏障后面的方法,允许分子分泌,同时避免免疫反应。这篇综述将概述与维持干细胞活力、指导分化、研究可扩展的生产方法以及移植干细胞治疗临床相关疾病相关的微囊化过程和特性。